-
The Treatment Gap and How to Fix It
The Osteoporosis Treatment Gap and How to Fix It by Douglas Bauer, MD from NCIBH on Vimeo. >Dr. Bauer presents an update on how to address the osteoporosis treatment gap. Recorded at Northern California Institute for Bone Health, on May 31 2019, in 14th Annual Meeting UPDATE ON OSTEOPOROSIS AND […]
-
Update on denosumab
Update on denosumab from NCIBH on Vimeo. Dr. McClung presents an update on denosumab. Recorded at Northern California Institute for Bone Health, on May 31 2019, in 14th Annual Meeting UPDATE ON OSTEOPOROSIS AND SKELETAL HEALTH.
-
Glucocorticoid-induced Osteoporosis: An Update
Glucocorticoid-induced Osteoporosis: An Update from NCIBH on Vimeo. Dr. Maricic presents a lecture on Glucocorticoid-induced Osteoporosis. Recorded at Northern California Institute for Bone Health, on May 31 2019, in 14th Annual Meeting UPDATE ON OSTEOPOROSIS AND SKELETAL HEALTH.
-
FGF-23 and Klotho
FGF23 Klotho Ott from NCIBH on Vimeo. Dr. Ott presents lecture on FGF-23 and Klotho. Recorded at Northern California Institute for Bone Health, on May 31 2019, in 14th Annual Meeting UPDATE ON OSTEOPOROSIS AND SKELETAL HEALTH.
-
Genetic Markers for Osteoporosis and Musculoskeletal Injuries
Genetic Markers for Osteoporosis and Musculoskeletal Injuries – Stuart Kim, PhD from NCIBH on Vimeo. Dr. Kim presents lecture on genetic markers for osteoporosis and musculoskeletal injuries. Recorded at Northern California Institute for Bone Health, on May 31 2019, in 14th Annual Meeting UPDATE ON OSTEOPOROSIS AND SKELETAL HEALTH.
-
What the Primary Care Provider Should Know About Bisphosphonate Therapy
What the Primary Care Provider Should Know About Bisphosphonate Therapy – Elliott N Schwartz, MD from NCIBH on Vimeo. Dr. Schwartz presents lecture on Bisphosphonate Therapy Recorded at Northern California Institute for Bone Health, on May 31 2019, in 14th Annual Meeting UPDATE ON OSTEOPOROSIS AND SKELETAL HEALTH.
-
Surrogates for Fracture Endpoints: Bone Mineral Density and Bone Turnover Markers; A Study by the Foundation for the National Institutes of Health (FNIH)
Surrogates for Fracture Endpoints – Douglas Bauer, MD from NCIBH on Vimeo. Dr. Bauer presents surrogates for fracture endpoints Recorded at Northern California Institute for Bone Health, on May 31 2019, in 14th Annual Meeting UPDATE ON OSTEOPOROSIS AND SKELETAL HEALTH.
-
15th Annual Meeting
Ticket Type Price Cart Physicians $75 Allied Health Professionals/ Residents/Fellows $50
Agenda: Update on Osteoporosis and Skeletal Health 2020
7:30- 8:00 Registration and Continental Breakfast 8:00- 8:05 Introduction
Elliott N. Schwartz, MD, Program Moderator8:05- 8:50 Senescence and Aging
Sundeep Khosla, MD8:50- 9:35 Update on Sclerostin: 2020
Matthew Drake, MD, PhD9:35- 10:20 What Every Physician Should Know About Bone Density Testing for Their Patients, Their Families and Themselves
Elliott N. Schwartz, MD, CCD, CPD10:20- 10:40 Break 10:40- 11:25 Update on Estrogen for Osteoporosis in the Modern Era
Risa Kagan, MD11:25- 12:10 Osteoporosis: Why We Overtreat Low-Risk Patients and Undertreat High-Risk Patients?
Paul D. Miller, MD12:10- 12:30 Morning Session Panel Q&A 12:30- 1:15 Lunch with the Faculty 1:15- 2:00 Celiac Disease, Inflammatory Bowel Disease, and Bone Health
Robin Dore, MD2:00- 2:45 Clinical Management of Fractures While on Osteoporosis Therapy
Robert Wermers, MD2:45- 3:00 Break 3:00- 3:45 3 Anabolic Bone Drugs: Differences and Similarities and Some Useful Clinical Pearls
Kelly Krohn, MD3:45- 4:30 Nutrition and Osteoporosis 2020: Truths, Half-Truths and Un-Truths
Sarah Morgan, MD4:30- 5:15 The Treatment Gap and How to Close It
Sundeep Khosla, MD5:15- 5:25 Afternoon Session Panel Q&A 5:25- 5:30 Conclusion and Evaluation
After this meeting, attendees will be able to:
- Apply the principles of DXA acquisition and analysis to the correct clinical interpretation of the studies
- Recognize the changes that have taken place in the concepts and facts of estrogen therapy for osteoporosis over the last 20 years
- Explain the effect of bowel diseases on bone health
- Describe the importance of sclerostin in skeletal health
- Explain the treatment strategies for osteoporosis and osteoporotic fractures
Accreditation
This Live activity, Update on Osteoporosis and Skeletal Health 2020, with a beginning date of 03/27/2020, has been reviewed and is acceptable for up to 8.00 Elective credits by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
There are no refunds for this event.
-
Recent Awards
Congratulations to Dr. Schwartz for being selected as a Fellow of the American Society for Bone and Mineral Research (ASBMR) Advisory Committee, and the Ellis Island Award to Dr. Bilezikian.
-
Major Advance In Bone Densitometry
On November 11, 2013, we installed a new recently FDA approved software to our bone density machines which produces a report known as Trabecular Bone Score (TBS). TBS creates a textured image from the spine DXA image. It involves NO added radiation for you but analyzes the spine DXA image in a different way to enable us to better define your fracture risk.
-
Diseases and Conditions that May Cause Bone Loss
Many health problems can increase your chance of getting osteoporosis. Ask your healthcare provider if you have any diseases or conditions that can cause bone loss. If you do, it’s important to take action to keep your bones healthy. In some cases, when you treat a health problem that causes bone loss, you can improve your bone health.
-
Detection of Vertebral Fractures
Despite the importance of vertebral compression fractures, there is much that remains uncertain. There is no “gold standard” for the definition which has led to epidemiologic and study differences. Height loss is a way to suspect vertebral fractures but it has its own issues.There are multiple radiographic systems for defining vertebral fractures, both prevalent and incident; risk factors for prevalent fractures have already been delineated. Recent studies have elucidated the risk factors for incident vertebral fractures including age, low weight, late menarche, lower bone mineral density, history of vertebral and nonvertebral fractures, smoking, and use of a walking aid.